Shields Matthew — SEC Form 4 filings
SEC reporting owner CIK 2025621. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-05 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 49,685 shares, $1,507,210 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 17,295 shares @ $31.67 ($547,705) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2026-03-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Global Operations | 7 | — | 4 legs · 49,685 sh · $1,507,210 | 9 |
Form 4 filings — Shields Matthew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 9,989 @ $32.19 | EDGAR |
| 2026-06-04 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 16,195 · Sale (S): 16,195 @ $32.87 · Option exercise (M): 16,195 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 33,424 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 16,195 · Sale (S): 6,206 @ $17.02 · Option exercise (M): 16,195 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 69,182 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 64,782 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2025621 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →